Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Planning and Dissemination Grants - Institute/Initiative Community Support

University of Toronto

$25,000.00

From Protocol to Practice: Co-Creation of Analytic Tools and A Capacity Building Initiative for Vaccine Effectiveness and Impact Evaluation in the African Meningitis Belt

EF 2026-27

Résumé
Meningococcal meningitis is a bacterial infection transmitted between people through close contact. There are about 250,000 meningococcal cases reported each year, with the majority occurring in the African Meningitis Belt (AMB), a region spanning 26 countries from Senegal to Ethiopia. In the AMB, explosive seasonal meningitis epidemics occur annually and can lead to thousands of cases with 10-15% resulting in death. A new vaccine, Men5CV, has recently been introduced in several AMB countries and offers protection against the five primary epidemic-causing meningococcal serogroups. Generating evidence on Men5CV effectiveness and impact is essential for guiding appropriate vaccination policy across the AMB. However, there are limited meningococcal vaccine evaluation protocols adapted to the AMB data environment and health-system context. This project brings together academics and technical implementing partners embedded within local Ministries of Health (MoH) to develop Men5CV evaluation tools shaped by and accessible to the countries most affected by meningitis in the AMB. Our team will (1) co-develop and publish an open access standardized Men5CV evaluation protocol adapted for AMB settings, (2) co-develop an analytical toolkit and deliver in-person capacity-building workshops in Burkina Faso, Niger, and Nigeria aimed at equipping MoH staff with the analytic skills to conduct long-term vaccine evaluations, and (3) identify priority analytic gaps to inform a future locally-led research agenda on immunization monitoring across the AMB. These activities will provide global public health practitioners and policymakers with standardized, context-specific tools to evaluate Men5CV programs and support evidence-informed immunization policies. Additionally, the unique tools to be developed in this project are flexible and can serve as a platform to be adapted for examining other vaccine-preventable diseases in global populations.
Programme
Planning and Dissemination Grants - Institute/Initiative Community Support
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
574119
Name
Berry Isha
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Population and Public Health
Theme2
Social / Cultural / Environmental / Population Health
Prcname2
Planning and Dissemination Grants
Projecttitle
From Protocol to Practice: Co-Creation of Analytic Tools and A Capacity Building Initiative for Vaccine Effectiveness and Impact Evaluation in the African Meningitis Belt
Programtype2
Miscellaneous Programs
Orgnameinp2
University of Toronto
Cihramount2
$25,000
Cihrequipment2
$0
Programname2
Planning and Dissemination Grants - Institute/Initiative Community Support
Keyworddelim
Capacity Building; Global Health; Meningococcal Disease; Quasi-Experimental Designs; Surveillance; Vaccine Epidemiology
Abstract
Meningococcal meningitis is a bacterial infection transmitted between people through close contact. There are about 250,000 meningococcal cases reported each year, with the majority occurring in the African Meningitis Belt (AMB), a region spanning 26 countries from Senegal to Ethiopia. In the AMB, explosive seasonal meningitis epidemics occur annually and can lead to thousands of cases with 10-15% resulting in death. A new vaccine, Men5CV, has recently been introduced in several AMB countries and offers protection against the five primary epidemic-causing meningococcal serogroups. Generating evidence on Men5CV effectiveness and impact is essential for guiding appropriate vaccination policy across the AMB. However, there are limited meningococcal vaccine evaluation protocols adapted to the AMB data environment and health-system context. This project brings together academics and technical implementing partners embedded within local Ministries of Health (MoH) to develop Men5CV evaluation tools shaped by and accessible to the countries most affected by meningitis in the AMB. Our team will (1) co-develop and publish an open access standardized Men5CV evaluation protocol adapted for AMB settings, (2) co-develop an analytical toolkit and deliver in-person capacity-building workshops in Burkina Faso, Niger, and Nigeria aimed at equipping MoH staff with the analytic skills to conduct long-term vaccine evaluations, and (3) identify priority analytic gaps to inform a future locally-led research agenda on immunization monitoring across the AMB. These activities will provide global public health practitioners and policymakers with standardized, context-specific tools to evaluate Men5CV programs and support evidence-informed immunization policies. Additionally, the unique tools to be developed in this project are flexible and can serve as a platform to be adapted for examining other vaccine-preventable diseases in global populations.
Competitiondate
202606
Approvedterm2
1 yr 0 mth
Pinamesdelim
Berry, Isha
Approvedterm
1 an 0 mois
Cihrcontribution2
Strat Initiatives 1~ $25,000~ $0~